Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed Nov 8, 2023. Long positions only.
- Positions
- 74
- No 13F data for Q4 2020
- Portfolio value
- $1.22B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AMRNAmarin Corp PLC | SPONS ADR NEW | 16,896,796 | $104.9M | 8.6% | – | – | History |
| UTHRUnited Therapeutics Corp | COM | 486,529 | $81.4M | 6.7% | – | – | History |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 806,932 | $71.6M | 5.9% | – | – | – |
| ALXNAlexion Pharmaceuticals, Inc. | COM | 465,983 | $71.3M | 5.8% | – | – | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 695,459 | $64.0M | 5.2% | – | – | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 4,354,756 | $50.3M | 4.1% | – | – | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 992,315 | $49.3M | 4.0% | – | – | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 311,867 | $40.2M | 3.3% | – | – | History |
| DHRDanaher Corp | Stock | 177,534 | $40.0M | 3.3% | – | – | History |
| TGTXTG Therapeutics, Inc. | COM | 762,589 | $36.8M | 3.0% | – | – | History |
| XLRNAcceleron Pharma Inc | COM | 241,981 | $32.8M | 2.7% | – | – | History |
| CYHCommunity Health Systems Inc | COM | 2,405,834 | $32.5M | 2.7% | – | – | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 4,755,480 | $32.0M | 2.6% | – | – | History |
| GSKGSK plc | SPONSORED ADR | 852,206 | $31.1M | 2.5% | – | – | History |
| NVSTEnvista Holdings Corp | COM | 732,684 | $29.9M | 2.4% | – | – | History |
| AVTRAvantor, Inc. | COM | 958,987 | $27.7M | 2.3% | – | – | History |
| OCDXOrtho Clinical Diagnostics Holdings plc | ORD SHS | 1,375,228 | $26.5M | 2.2% | – | – | History |
| FATEFate Therapeutics Inc | COM | 321,760 | $26.5M | 2.2% | – | – | History |
| MCKMcKesson Corp | Stock | 122,983 | $24.0M | 2.0% | – | – | History |
| ELVElevance Health, Inc. | Stock | 63,892 | $22.9M | 1.9% | – | – | History |
| QGENQiagen N.V. | SHS NEW | 454,721 | $22.1M | 1.8% | – | – | History |
| CTLTCatalent, Inc. | COM | 163,114 | $17.2M | 1.4% | – | – | History |
| BDXBecton Dickinson & Co | Stock | 68,383 | $16.6M | 1.4% | – | – | History |
| BHVNBiohaven Ltd. | COM | 242,172 | $16.6M | 1.4% | – | – | History |
| HCAHCA Healthcare, Inc. | COM | 85,409 | $16.1M | 1.3% | – | – | History |
| ZGNXZogenix, Inc. | COM NEW | 823,229 | $16.1M | 1.3% | – | – | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 345,717 | $15.5M | 1.3% | – | – | History |
| Taro Pharmaceutical Inds LtdM8737E108 | SHS | 164,378 | $12.1M | 1.0% | – | – | – |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 80,937 | $11.4M | 0.9% | – | – | History |
| ACADAcadia Pharmaceuticals Inc | COM | 420,000 | $10.8M | 0.9% | – | – | History |
| HUMHumana Inc | Stock | 24,839 | $10.4M | 0.9% | – | – | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 300,587 | $10.2M | 0.8% | – | – | History |
| ARGXArgenx SE | SPONSORED ADR | 35,886 | $9.88M | 0.8% | – | – | History |
| ARK Innovation ETF00214Q104 | ETF | 82,000 | $9.84M | 0.8% | – | – | – |
| MGLNMagellan Health Inc | COM NEW | 104,700 | $9.76M | 0.8% | – | – | History |
| CICigna Group | Stock | 40,000 | $9.67M | 0.8% | – | – | History |
| MNKDMannkind Corp | COM NEW | 2,165,383 | $8.49M | 0.7% | – | – | History |
| Affimed N VN01045108 | COM | 1,046,129 | $8.27M | 0.7% | – | – | – |
| DXCMDexcom Inc | COM | 18,741 | $6.74M | 0.6% | – | – | History |
| GHGuardant Health, Inc. | COM | 40,247 | $6.14M | 0.5% | – | – | History |
| NVAXNovavax Inc | COM NEW | 33,473 | $6.07M | 0.5% | – | – | History |
| NTRANatera, Inc. | COM | 57,700 | $5.86M | 0.5% | – | – | History |
| CNCCentene Corp | Stock | 91,120 | $5.82M | 0.5% | – | – | History |
| SRGASurgalign Holdings, Inc. | COM | 2,639,784 | $5.75M | 0.5% | – | – | History |
| KDMNKadmon Holdings, Inc. | COM | 1,373,119 | $5.34M | 0.4% | – | – | History |
| MCRBSeres Therapeutics, Inc. | COM | 215,276 | $4.43M | 0.4% | – | – | History |
| LMNXLuminex Corp | COM | 135,471 | $4.33M | 0.4% | – | – | History |
| IMVTImmunovant, Inc. | COM | 230,183 | $3.69M | 0.3% | – | – | History |
| Five Prime Therapeutics Inc33830X104 | COM | 93,280 | $3.51M | 0.3% | – | – | – |
| ENSGEnsign Group, Inc | COM | 28,883 | $2.71M | 0.2% | – | – | History |
| SRDXSurmodics Inc | COM | 47,906 | $2.69M | 0.2% | – | – | History |
| Alpha Healthcare Acquistn Co020751103 | CL A | 239,026 | $2.59M | 0.2% | – | – | – |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 410,593 | $2.41M | 0.2% | – | – | History |
| AAgilent Technologies, Inc. | COM | 15,261 | $1.94M | 0.2% | – | – | History |
| ISRGIntuitive Surgical Inc | COM NEW | 2,583 | $1.91M | 0.2% | – | – | History |
| HSKAHeska Corp | COM RESTRC NEW | 11,040 | $1.86M | 0.2% | – | – | History |
| XGNExagen Inc. | COM | 104,437 | $1.83M | 0.1% | – | – | History |
| PRTAProthena Corp Public Ltd Co | SHS | 68,575 | $1.72M | 0.1% | – | – | History |
| KROSKeros Therapeutics, Inc. | COM | 27,631 | $1.70M | 0.1% | – | – | History |
| XENTIntersect ENT, Inc. | COM | 75,389 | $1.57M | 0.1% | – | – | History |
| Teligent, Inc.87960W203 | COM NEW | 2,500,260 | $1.56M | 0.1% | – | – | – |
| CFMSConformis Inc | COM NEW | 1,541,978 | $1.53M | 0.1% | – | – | History |
| LQDALiquidia Corp | COM NEW | 500,010 | $1.35M | 0.1% | – | – | History |
| IQVIQVIA Holdings Inc. | Stock | 5,921 | $1.14M | 0.1% | – | – | History |
| CHWYChewy, Inc. | CL A | 13,100 | $1.11M | 0.1% | – | – | History |
| RADNew Rite Aid, LLC | COM | 54,025 | $1.11M | 0.1% | – | – | History |
| IFRXInflaRx N.V. | COM | 268,634 | $1.05M | 0.1% | – | – | History |
| CABACabaletta Bio, Inc. | COM | 76,849 | $853.0K | 0.1% | – | – | History |
| GOCOGoHealth, Inc. | COM CL A | 68,899 | $805.4K | 0.1% | – | – | History |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 249,895 | $767.2K | 0.1% | – | – | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 12,900 | $553.5K | <0.1% | – | – | History |
| QDELQuidelOrtho Corp | COM | 4,132 | $528.6K | <0.1% | – | – | History |
| APTOAptose Biosciences Inc. | COM NEW | 80,000 | $478.0K | <0.1% | – | – | History |
| RGENRepligen Corp | COM | 1,428 | $277.6K | <0.1% | – | – | History |
Options (10)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| GSKGSK plc | SPONSORED ADR | – | $41.2M |
| SPYSPDR S&P 500 ETF Trust | ETF | $39.6M | – |
| VRTXVertex Pharmaceuticals Inc | Stock | – | $12.9M |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | $5.05M | – |
| CNCCentene Corp | Stock | – | $3.20M |
| AMRNAmarin Corp PLC | SPONS ADR NEW | – | $2.74M |
| KRROKorro Bio, Inc. | COM | $1.84M | $94.8K |
| NVAXNovavax Inc | COM NEW | – | $1.81M |
| ACADAcadia Pharmaceuticals Inc | COM | – | $645.0K |
| OTICOtonomy, Inc. | COM | – | $505.9K |